Perry Drug Inc. recalls Testosterone CYP-250/PROP-20 mg, 10 Ml Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- ND
Recalled December 3, 2014 · FDA recall D-0259-2015 · Perry Drug
Hazard
Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection. · FDA Class II
Units
1 vial
Sold at
Kansas and Missouri
Description
Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
Product
Testosterone CYP-250/PROP-20 mg, 10 Ml Syringe, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC 88888-0326-44
Manufacturer(s)
Perry Drug Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →